Azithromycin NDC 71205-645

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-645Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0645Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71205-645-06	71205064506	6 DOSE PACK in 1 CARTON (71205-645-06) / 1 TABLET, FILM COATED in 1 DOSE PACKMarketed from Mar 18, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Azithromycin
Generic name (nonproprietary): azithromycin
Active ingredients: Azithromycin dihydrate — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065211
Marketing start: Nov 14, 2005
Listing expires: Dec 31, 2026
Other FDA classes: Macrolides (Chemical structure)
Identifiers: Product ID 71205-645_8e6754bd-b54c-41db-ae4b-a69b9f8424d8SPL ID 8e6754bd-b54c-41db-ae4b-a69b9f8424d8SPL set ID 38942011-f86b-4e42-a4ca-05a70d9dd3d9RxCUI 308460, 749783UNII 5FD1131I7SUPC 0371205645069
Pharmacologic class: Macrolide Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205064506 followed by a unit qualifier and the quantity

Package 71205-0645-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 1, 2024.

Indications (excerpt from the label)

Azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications [see Dosage and Administration ( 2 )]. Azithromycin tablets are a macrolide antibacterial drug indicated for mild to moderate infections caused by designated, susceptible bacteria: • Acute bacterial exacerbations of chronic bronchitis in adults ( 1.1 ) • Acute bacterial sinusitis in adults ( 1.1 ) • Uncomplicated skin and skin structure infections in adults ( …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065211

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065211
Product	Strength	Form · route	Labeler	Product NDC
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-8124
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Sportpharm LLC	85766-008
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Sandoz Inc	0781-8089
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-213